Valstar preservative free and Xyzal drug interactions - a phase IV clinical study of FDA data
Summary:
We study 21,542 people who take Valstar preservative free (valrubicin) and Xyzal (levocetirizine dihydrochloride). There is no drug interaction reported.
The study analyzes what interactions people have when they take Valstar preservative free and Xyzal. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Valstar preservative free?
Valstar preservative free has active ingredients of valrubicin. eHealthMe is studying from 63 Valstar preservative free users. Check the latest studies of Valstar preservative free.
What is Xyzal?
Xyzal has active ingredients of levocetirizine dihydrochloride. It is often used in allergies. eHealthMe is studying from 21,479 Xyzal users. Check the latest studies of Xyzal.
No report is found.
Do you take Valstar preservative free and Xyzal?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Valstar preservative free (63 reports)
- Xyzal (21,479 reports)
How the study uses the data?
The study uses data from the FDA. It is based on valrubicin and levocetirizine dihydrochloride (the active ingredients of Valstar preservative free and Xyzal, respectively), and Valstar preservative free and Xyzal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Xyrem and Clindamycin Phosphate - 15 seconds ago
- Drug interactions of Levoxyl and Primrose Oil - 29 seconds ago
- Drug interactions of Rezurock and Oxycodone - 34 seconds ago
- Could Cetirizine Hydrochloride cause Taste - Impaired? - 50 seconds ago
- Could Victoza cause Injection Site Urticaria? - a minute ago
- Could Gravol cause Irritable Bowel Syndrome? - a minute ago
- Could Lipitor cause Gastric Ulcer? - a minute ago
- Could Marinol cause Haematuria Aggravated? - a minute ago
- Drug interactions of Darvocet and Feldene - a minute ago
- Drug interactions of Linagliptin and Apidra - a minute ago